1. Home
  2. CLOV vs VIR Comparison

CLOV vs VIR Comparison

Compare CLOV & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLOV
  • VIR
  • Stock Information
  • Founded
  • CLOV 2014
  • VIR 2016
  • Country
  • CLOV United States
  • VIR United States
  • Employees
  • CLOV N/A
  • VIR N/A
  • Industry
  • CLOV Medical Specialities
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLOV Health Care
  • VIR Health Care
  • Exchange
  • CLOV Nasdaq
  • VIR Nasdaq
  • Market Cap
  • CLOV 922.8M
  • VIR 1.0B
  • IPO Year
  • CLOV N/A
  • VIR 2019
  • Fundamental
  • Price
  • CLOV $3.09
  • VIR $7.94
  • Analyst Decision
  • CLOV
  • VIR Buy
  • Analyst Count
  • CLOV 0
  • VIR 6
  • Target Price
  • CLOV N/A
  • VIR $33.00
  • AVG Volume (30 Days)
  • CLOV 11.6M
  • VIR 630.3K
  • Earning Date
  • CLOV 11-04-2024
  • VIR 10-31-2024
  • Dividend Yield
  • CLOV N/A
  • VIR N/A
  • EPS Growth
  • CLOV N/A
  • VIR N/A
  • EPS
  • CLOV N/A
  • VIR N/A
  • Revenue
  • CLOV $2,089,870,000.00
  • VIR $78,877,000.00
  • Revenue This Year
  • CLOV N/A
  • VIR N/A
  • Revenue Next Year
  • CLOV $5.80
  • VIR N/A
  • P/E Ratio
  • CLOV N/A
  • VIR N/A
  • Revenue Growth
  • CLOV N/A
  • VIR N/A
  • 52 Week Low
  • CLOV $0.61
  • VIR $7.41
  • 52 Week High
  • CLOV $3.82
  • VIR $13.09
  • Technical
  • Relative Strength Index (RSI)
  • CLOV 60.85
  • VIR 44.94
  • Support Level
  • CLOV $2.47
  • VIR $7.58
  • Resistance Level
  • CLOV $2.99
  • VIR $8.07
  • Average True Range (ATR)
  • CLOV 0.23
  • VIR 0.31
  • MACD
  • CLOV -0.03
  • VIR 0.05
  • Stochastic Oscillator
  • CLOV 58.73
  • VIR 53.85

About CLOV Clover Health Investments Corp.

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: